Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check6 days agoChange DetectedAdded references under related topics (including Ovarian cancer / MedlinePlus Genetics) and updated the displayed site revision version. Removed an older revision label (Revision: v3.5.0), with the page now showing Revision: v3.5.2.SummaryDifference0.1%

- Check13 days agoChange DetectedRemoved the related topics 'Ovarian cancer' and 'MedlinePlus Genetics' from the related topics section.SummaryDifference0.0%

- Check20 days agoChange DetectedAdded related topics links for Ovarian cancer and MedlinePlus Genetics on the study page.SummaryDifference0.0%

- Check27 days agoChange DetectedRemoved the 'Ovarian cancer' condition tag and the related topic 'MedlinePlus Genetics' from the page, reducing visible context and linked related information.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded related topic tags for 'Ovarian cancer' and 'MedlinePlus Genetics', and updated the site revision from v3.4.3 to v3.5.0. These changes mainly impact navigation and versioning rather than the study details.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved related topics entries 'Ovarian cancer' and 'MedlinePlus Genetics' from the Related Topics section.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.